Trigger Point Injections for Myofascial Pain

Palo Alto (17 mi)

Overseen byMohab Ibrahim, Md., Ph.D

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Waitlist Available

Sponsor: University of Arizona

No Placebo Group

Prior Safety Data

Trial Summary

What is the purpose of this trial?This trial studies how different numbers of needle passes during trigger point injections affect pain relief in patients with chronic myofascial pain. The treatment involves injecting a numbing medicine into painful muscle areas and moving the needle in and out multiple times. The goal is to find out which method provides the best pain relief.

Eligibility Criteria

This trial is for English-speaking individuals with myofascial pain who haven't found relief through conservative treatments or can't do physical therapy. It's not suitable for those with serious mental illnesses that affect pain perception or conditions causing widespread pain.

Inclusion Criteria

I have been diagnosed with muscle pain.

Physical therapy did not work for me or I cannot do it.

Exclusion Criteria

I have a mental illness that affects my ability to feel changes in pain.

Treatment Details

The study tests how many needle passes in trigger point injections (using lidocaine and bupivacaine) are best for relieving chronic muscle pain. Participants will be randomly assigned to receive either 2, 10, or 20 needle passes at a clinic in Tucson, Arizona.

3Treatment groups

Active Control

Group I: One to two needle passesActive Control1 Intervention

Receive 1-2 needle passes for needling at each trigger point

Group II: Ten needle passesActive Control1 Intervention

Receive 10 needle passes for needling at each trigger point

Group III: Twenty needle passesActive Control1 Intervention

Receive 20 needle passes for needling at each trigger point